- Home
- PRTA vs FRA Comparison
PRTA vs FRA Comparison
Compare PRTA & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- FRA
- Stock Information
- Founded
- PRTA 2012
- FRA 2003
- Country
- PRTA Ireland
- FRA United States
- Employees
- PRTA N/A
- FRA N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- FRA Investment Bankers/Brokers/Service
- Sector
- PRTA Health Care
- FRA Finance
- Exchange
- PRTA Nasdaq
- FRA Nasdaq
- Market Cap
- PRTA 472.1M
- FRA 466.7M
- IPO Year
- PRTA N/A
- FRA N/A
- Fundamental
- Price
- PRTA $8.16
- FRA $13.19
- Analyst Decision
- PRTA Buy
- FRA
- Analyst Count
- PRTA 10
- FRA 0
- Target Price
- PRTA $12.29
- FRA N/A
- AVG Volume (30 Days)
- PRTA 935.9K
- FRA 165.4K
- Earning Date
- PRTA 11-11-2025
- FRA 01-01-0001
- Dividend Yield
- PRTA N/A
- FRA 11.06%
- EPS Growth
- PRTA N/A
- FRA N/A
- EPS
- PRTA N/A
- FRA N/A
- Revenue
- PRTA $10,341,000.00
- FRA N/A
- Revenue This Year
- PRTA N/A
- FRA N/A
- Revenue Next Year
- PRTA $389.77
- FRA N/A
- P/E Ratio
- PRTA N/A
- FRA N/A
- Revenue Growth
- PRTA N/A
- FRA N/A
- 52 Week Low
- PRTA $4.32
- FRA $11.33
- 52 Week High
- PRTA $22.71
- FRA $13.10
- Technical
- Relative Strength Index (RSI)
- PRTA 51.80
- FRA 44.02
- Support Level
- PRTA $8.19
- FRA $13.23
- Resistance Level
- PRTA $8.50
- FRA $13.41
- Average True Range (ATR)
- PRTA 0.33
- FRA 0.09
- MACD
- PRTA -0.09
- FRA -0.01
- Stochastic Oscillator
- PRTA 16.18
- FRA 27.42
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About FRA Blackrock Floating Rate Income Strategies Fund Inc
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.